NovoPro
Cart 2
  • Anti-NFkB p100/NFKB2 Rabbit antibody
  • Anti-NFkB p100/NFKB2 Rabbit antibody

Anti-NFkB p100/NFKB2 Rabbit antibody

Cat.#: 168892

Size:

Special Price 441.3 USD

Availability: In Stock
- +

Add to cart to get an online quotation

Product Information

  • Product Name
    Anti-NFkB p100/NFKB2 Rabbit antibody
  • Documents
  • Description
    NFkB p100/NFKB2 Rabbit monoclonal antibody
  • Tested applications
    WB, ICC/IF, IP
  • Species reactivity
    Human, Mouse, Rat
  • Alternative names
    p52; p100; H2TF1; LYT10; CVID10; LYT-10; NF-kB2; p49/p100 antibody
  • Isotype
    Rabbit IgG
  • Preparation
    Antigen: Recombinant protein of human NFkB p100
  • Clonality
    Monoclonal antibody
  • Formulation
    Supplied in 50nM Tris-Glycine(pH 7.4), 0.15M Nacl, 40%Glycerol, 0.01% sodium azide and 0.05% BSA.
  • Storage instructions
    Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze / thaw cycle.
  • Applications

    1:2000-1:10000

    1:50

    1:20

  • Validations

    Immunocytochemistry of NFkB p100(green) in Hela cells using NFkB p100 Rabbit mAb at dilution 1/200, and DAPI(blue)

    Immunocytochemistry of NFkB p100(green) in Hela cells using NFkB p100 Rabbit mAb at dilution 1/200, and DAPI(blue)

    Western blot detection of NFkB p100/NFKB2 in C6,3T3,Hela cell lysates using NFkB p100/NFKB2 Rabbit mAb(1:1000 diluted).Predicted band size:97kDa.Observed band size:100kDa.

    Western blot detection of NFkB p100/NFKB2 in C6,3T3,Hela cell lysates using NFkB p100/NFKB2 Rabbit mAb(1:1000 diluted).Predicted band size:97kDa.Observed band size:100kDa.

  • Background
    Swiss-Prot Acc.Q00653.NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. In a non-canonical activation pathway, the MAP3K14-activated CHUK/IKKA homodimer phosphorylates NFKB2/p100 associated with RelB, inducing its proteolytic processing to NFKB2/p52 and the formation of NF-kappa-B RelB-p52 complexes. The NF-kappa-B heterodimeric RelB-p52 complex is a transcriptional activator. The NF-kappa-B p52-p52 homodimer is a transcriptional repressor. NFKB2 appears to have dual functions such as cytoplasmic retention of attached NF-kappa-B proteins by p100 and generation of p52 by a cotranslational processing. The proteasome-mediated process ensures the production of both p52 and p100 and preserves their independent function. p52 binds to the kappa-B consensus sequence 5'-GGRNNYYCC-3', located in the enhancer region of genes involved in immune response and acute phase reactions. p52 and p100 are respectively the minor and major form; the processing of p100 being relatively poor. Isoform p49 is a subunit of the NF-kappa-B protein complex, which stimulates the HIV enhancer in synergy with p65. In concert with RELB, regulates the circadian clock by repressing the transcriptional activator activity of the CLOCK-ARNTL/BMAL1 heterodimer.
  • References

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"